Lupus Nephritis, the therapy and the role of Rituximab in resistant cases
Background Systemic lupus erythematosus (SLE) is a common autoimmune disease that affects mainly young females and nephritis is an important complication of the disease that may end with end stage renal disease (ESRD). Early diagnosis and proper treatment is important in decreasing the morbidity. M...
Main Authors: | Hussein A. Nasir, Yasir F. Sharba, Nadia A. Nasir |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine University of Baghdad
2014-01-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/574 |
Similar Items
-
USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01) -
Clinical efficacy and safety of rituximab in lupus nephritis
by: Zhong Z, et al.
Published: (2019-03-01) -
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
by: Luca Petricca, et al.
Published: (2020-10-01) -
Clinical And Morphological Improvement Of Lupus Nephritis Treated With Rituximab
by: Tsanyan Maria E., et al.
Published: (2014-12-01) -
Immunoglobulin abnormalities are frequent in patients with lupus nephritis
by: M. J. Cuadrado, et al.
Published: (2019-08-01)